$8 Billion Risperdal Judgment Reduced to $6.8 Million

The judge presiding over a case which saw Johnson & Johnson hit with an $8bn jury verdict has reduced the amount the company has to pay in damages to $6.8m.

Last October, J&J was ordered to pay $8bn in damages to a US man who claims he was not warned that taking the company’s antipsychotic Risperdal could lead to breast growth.

A jury in Philadelphia agreed with the allegation that J&J’s Janssen unit had downplayed the risk that use of Risperdal (risperidone) in male children can cause enlarged breasts, a condition known as gynaecomastia.

Stanford Law Experts on Johnson & Johnson Product Liability Exposure

Johnson & Johnson is facing tens of thousands of product liability lawsuits, involving, among other things, its antipsychotic drug Risperdal, opioids, vaginal mesh, and talcum powder.

Here, Stanford Law Professor Nora Freeman Engstrom, a tort law and complex litigation expert, and Diana Garnet Li, a student in the Stanford Law School Class of 2021, discuss the mounting product liability exposure facing the multinational giant—and how these cases may develop.

Men Say Risperdal Caused Them to Grow Breasts

A lawsuit is expected to be filed soon on behalf of men who have used the drug Risperdal.

The plaintiffs say the drug, used to treat conditions such as anxiety and bipolar disorder, caused them to grow breasts, according to a report on CNN.

The men say the side effect was not disclosed in a timely manner by the drug company, Johnson & Johnson.

Janssen Accused of Withholding Data on Risperdal Side Effect in Autism

Janssen Pharmaceuticals, manufacturer of a drug widely used in autistic children, omitted data on its side effects from a 2003 study, according to evidence presented during a lawsuit against the company.

Risperidone, marketed by Janssen as Risperdal, is one of only two drugs approved for autism. It was developed as an antipsychotic for adults with schizophrenia in 1993. Initially, it was not deemed safe for prepubescent children because it can boost levels of prolactin. Elevated prolactin levels are linked to a range of side effects, including gynecomastia in men and boys.

J&J Pays $2.2 Billion in Risperdal Damages

In one of the country’s largest health care-related settlements, pharmaceutical giant Johnson & Johnson paid $2.2 billion to settle charges of false marketing, and paying doctors and nursing homes kickbacks for promoting drugs for unapproved uses.

Officials with the U.S. Department of Justice alleged that Johnson & Johnson promoted the use of Risperdal, a drug approved by the Food and Drug Administration only for the treatment of schizophrenia, for controlling symptoms of anxiety and aggression in elderly dementia patients, as well as in children and the mentally disabled with behavioral problems.

Still have questions?

Call (877) 932-2628 and speak with one of our legal funding experts.

* Word-Use Disclaimer

Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in plaintiffs’ legal claims. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for marketing purposes only.
More info

TriMark Legal Funding LLC
1056 Green Acres Rd #102
Eugene, OR 97408